A randomized clinical trial in preterm infants on the effects of a home-based early intervention with the CareToy SystemReportar como inadecuado

A randomized clinical trial in preterm infants on the effects of a home-based early intervention with the CareToy System - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

CareToy system is an innovative tele-rehabilitative tool, useful in providing intensive, individualized, home-based, family-centred Early Intervention EI in infants. Our aim was to evaluate, through a Randomized Clinical Trial RCT study, the effects of CareToy intervention on early motor and visual development in preterm infants. 41 preterm infants range age: 3.0–5.9 months of corrected age were enrolled and randomized into two groups, CareToy and Standard Care. 19 infants randomized in CareToy group performed a 4-week CareToy program, while 22 allocated to control group completed 4 weeks of Standard Care. Infant Motor Profile IMP was primary outcome measure, Alberta Infant Motor Scale AIMS and Teller Acuity Cards were secondary ones. Assessments were carried out at baseline T0 and at the end of CareToy training or Standard Care period T1. T1 was the primary endpoint. After RCT phase, 17 infants from control group carried out a 4-week CareToy program, while 18 infants from the CareToy group continued with Standard Care. At the end of this phase, infants were re-assessed at T2. In RCT phase, delta IMP total score and variation and performance sub-domains were significantly higher P<0.050 in CareToy group if compared to Standard Care group. Similar results were found for Teller Acuity Cards, while no differences between groups were found for AIMS. No differences were found in any outcome measure results T2-T0, between infants who started CareToy training before or after one month of standard care. This RCT study confirms the results of a previous pilot study, indicating that CareToy system can provide effective home-based EI.Trial Registration: This trial has been registered at www.clinicaltrials.gov Identifier NCT01990183.

Autor: Giuseppina Sgandurra , Jakob Lorentzen, Emanuela Inguaggiato, Laura Bartalena, Elena Beani, Francesca Cecchi, Paolo Dario, Matteo

Fuente: http://plos.srce.hr/


Documentos relacionados